Tenax Therapeutics Inc — Quarterly Cash Flow (NASDAQ:TENX) | MetaTrader

Open full chart

Financials

Overview Relatórios Statistics Dividends

Quarterly Annual

Total assets 99.78 M96.69 M112.06 M105.86 M102.81 M Total liabilities 2.56 M4.69 M2.77 M2.53 M6.6 M Total equity 97.22 M91.99 M109.29 M103.33 M96.21 M Total liabilities & shareholders' equities 99.78 M96.69 M112.06 M105.86 M102.81 M Total debt ————— Net debt —————

Notícias

Tenax Therapeutics: Some Future Potential (NASDAQ:TENX)

Tenax Therapeutics Stock: A Speculative Buy (NASDAQ:TENX)

Tenax: Lower Variance In Phase 3 Has "Loaded The Dice" For An Asymmetric Repricing

Tesla, Goldman Sachs among market cap stock movers on Monday

Estudo de fase 3 LEVEL da Tenax Therapeutics confirma meta de recrutamento

Tenax Therapeutics’ phase 3 LEVEL study confirms enrollment target

Preço-alvo das ações da Tenax Therapeutics elevado para US$ 25 por Guggenheim

Tenax Therapeutics stock price target raised to $25 from $14 at Guggenheim

Diretor da Tenax Therapeutics, Rich Stuart, compra US$ 50.792 em ações

Tenax Therapeutics director Rich Stuart buys $50,792 in stock

Giordano buys Tenax Therapeutics (TENX) shares worth $19,999

Diretor financeiro interino da Tenax Therapeutics compra ações no valor de US$ 58.164